ZYBT

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change +0.85
Percentage change 21.09	%

Index	-	P/E	82.02	EPS (ttm)	0.06	Insider Own	-	Shs Outstand	47.17M	Perf Week	8.44%
Market Cap	231.26M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-2.40%
Income	2.81M	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Sales	26.26M	P/S	8.81	EPS this Y	-	Inst Trans	0.01%	Short Ratio	0.28	Perf Half Y	-
Book/sh	0.82	P/B	5.94	EPS next Y	-	ROA	4.07%	Short Interest	0.03M	Perf Year	-
Cash/sh	0.02	P/C	197.66	EPS next 5Y	-	ROE	7.51%	52W Range	3.70 - 6.10	Perf YTD	0.41%
Dividend Est.	-	P/FCF	35.69	EPS past 5Y	-	ROI	7.24%	52W High	-20.00%	Beta	-
Dividend TTM	-	Quick Ratio	0.81	Sales past 5Y	-3.13%	Gross Margin	59.46%	52W Low	31.89%	ATR (14)	0.39
Dividend Ex-Date	-	Current Ratio	1.34	EPS Y/Y TTM	-55.43%	Oper. Margin	18.90%	RSI (14)	57.57	Volatility	10.70% 8.38%
Employees	275	Debt/Eq	0.31	Sales Y/Y TTM	-28.00%	Profit Margin	10.69%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	-57.05%	Payout	-	Rel Volume	2.27	Prev Close	4.03
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-21.95%	Earnings	-	Avg Volume	121.66K	Price	4.88
SMA20	10.58%	SMA50	9.45%	SMA200	9.25%	Trades		Volume	276,771	Change	21.09%

Jan-14-25 12:00PM	Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option (GlobeNewswire)
Jan-08-25 12:00PM	Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering (GlobeNewswire) -7.41%
Jan-06-25 05:50PM	Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering (GlobeNewswire)

Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. It offers a range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company was founded on March 24, 2023 and is headquartered in Jilin City, China.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Zhengye Biotechnology Holding Ltd

Upgrade your FINVIZ experience